People who inject drugs (PWID) are at high risk of contracting and transmitting hepatitis C virus (HCV), with an estimated 20% of PWID in Australia having viraemic infection. This bulletin reports on the result of self-reported engagement with testing and treatment for HCV, as well as results of dried blood spot (DBS) testing in 2018. 



Ms Daisy Gibbs, Prof Jason Grebely, Dr Sarah Larney, Dr Kerryn Butler, Dr Rachel Sutherland, Mr Mitchell Starr, Ms Antonia Karlsson, Ms Julia Uporova, Dr Amy Peacock
Date Commenced
23 Aug 2019
Resource Type
Drug Trends Bulletins